Akari Therapeutics Plc (AKTX)

7.75 +0.28 (+3.75%) USD  |  NASDAQ  |  Aug 25, 13:26
More

Akari Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2025. Start Trial.
Date Value
August 17, 2026 --
July 20, 2026 --
April 22, 2026 --
April 08, 2026 --
April 01, 2026 --
March 11, 2026 --
Date Value
March 05, 2026 --
January 05, 2026 --
December 22, 2025 --
September 09, 2025 --
August 14, 2025 --
July 18, 2025 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
DBV Technologies SA Upgrade
Cellectis SA Upgrade
argenx SE Upgrade
Autolus Therapeutics Plc Upgrade
Evaxion AS Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade